All Stories

  1. The Links between Cardiovascular Diseases and Alzheimer's Disease
  2. Insomnia and risk of dementia in older adults: Systematic review and meta-analysis
  3. Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial
  4. Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis
  5. Antidepressant use and associated factors among the elderly: the Bambuí Project
  6. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients
  7. Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis
  8. Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder
  9. Specific cognitive functions and depressive symptoms as predictors of activities of daily living in older adults with heterogeneous cognitive backgrounds
  10. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease
  11. Semantic network and executive aspects impact semantic verbal fluency task in healthy elderly, mild cognitive impairment, and Alzheimer’s disease patients
  12. Plasma and cerebrospinal fluid amyloid-b levels in late-life depression: A systematic review and meta-analysis
  13. Working Memory and Cognitive Flexibility Mediates Visuoconstructional Abilities in Older Adults with Heterogeneous Cognitive Ability
  14. Predictors of incidence of clinically significant depressive symptoms in the elderly: 10-year follow-up study of the Bambui cohort study of aging
  15. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature
  16. ADHD inattentive symptoms mediate the relationship between intelligence and academic performance in children aged 6-14
  17. Graph analysis of verbal fluency test discriminate between patients with Alzheimer's disease, mild cognitive impairment and normal elderly controls
  18. Long-Term, Low-Dose Lithium Treatment Does Not Impair Renal Function in the Elderly
  19. Major Depressive Disorder in Older Adults: Benefits and Hazards of Prolonged Treatment
  20. Impaired generation of new subcategories and switching in a semantic verbal fluency test in older adults with mild cognitive impairment
  21. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes
  22. Long-Term Lithium Treatment Reduces Glucose Metabolism in the Cerebellum and Hippocampus of Nondemented Older Adults: An [ 18 F]FDG-PET Study
  23. Cognitive Impairment in Euthymic Older Adults With Bipolar Disorder: A Controlled Study Using Cognitive Screening Tests
  24. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: A longitudinal study
  25. THE EFFECT OF GENDER, AGE, AND SYMPTOM SEVERITY IN LATE-LIFE DEPRESSION ON THE RISK OF ALL-CAUSE MORTALITY: THE BAMBUÍ COHORT STUDY OF AGING
  26. Clinical Applicability and Cutoff Values for an Unstructured Neuropsychological Assessment Protocol for Older Adults with Low Formal Education
  27. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
  28. Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
  29. Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression
  30. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders
  31. Transcriptional Alterations Related to Neuropathology and Clinical Manifestation of Alzheimer’s Disease
  32. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
  33. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
  34. Reduced serum levels of adiponectin in elderly patients with major depression
  35. Long-term sertraline treatment increases expression and phosphorilation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
  36. Reduced Serum Nerve Growth Factor in Patients With Late-Life Depression
  37. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease
  38. A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
  39. Biomarkers in Mood Disorders Among the Elderly: Can They Contribute to Diagnosis and Prognosis?
  40. Redução dos níveis séricos de ácido fólico em pacientes com a doença de Alzheimer
  41. Circulating Glial-derived neurotrophic factor is reduced in late-life depression
  42. Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies
  43. Brain-Derived Neurotrophic Factor and Alzheimer’s Disease: Physiopathology and Beyond
  44. Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders
  45. Serum nerve growth factor (NGF) level is reduced in mild cognitive impairment and Alzheimer's disease
  46. Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study
  47. Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains
  48. Platelet GSK3B activity in patients with late-life depression: Marker of depressive episode severity and cognitive impairment?
  49. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function
  50. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
  51. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment
  52. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment
  53. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement
  54. Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
  55. Autopercepção da saúde e desempenho cognitivo em idosos residentes na comunidade
  56. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression
  57. Diagnosis and biomarkers of predementia in Alzheimer's disease
  58. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
  59. Diagnostic transitions in mild cognitive impairment subtypes
  60. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education
  61. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease
  62. Diagnosis of Mild Cognitive Impairment Revisited after One Year
  63. Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment
  64. Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly
  65. Mild cognitive impairment: cognitive screening or neuropsychological assessment?
  66. Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil
  67. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education
  68. O uso de antipsicóticos em pacientes com diagnóstico de demência
  69. Cognitive training increases platelet PLA2 activity in healthy elderly subjects
  70. Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature
  71. Mini-mental State Examination performance in mild cognitive impairment subtypes
  72. Nível educacional e idade no desempenho no Miniexame do Estado Mental em idosos residentes na comunidade
  73. O uso de biomarcadores no líquido cefalorraquidiano no diagnóstico precoce da doença de Alzheimer
  74. Automutilação de dedos e lábio em paciente esquizofrênico
  75. A atividade da enzima Glicogênio Sintase Quinase 3 Beta (GSK-3B) em pacientes idosos com depressão maior: associação com parâmetros clínicos, psicopatológicos e cognitivos